PAVmed (PAVM) is scheduled to report Q2 earnings on August 13, 2026. Analysts estimate EPS of $-0.71 and quarterly revenue of $98.40K.
In the most recent quarter (Q1), PAVmed reported EPS of $-1.17, missing estimates of $-0.71 by 0.65%. Revenue came in at $22.00K, missing the estimate of $79.20K by 0.72%.
Over the last 4 quarters, PAVmed has averaged an EPS surprise of 0.78% and a revenue surprise of 0.70%.
Analyze the earnings history of PAVmed using advanced sorting and filters.
The chart below shows PAVmed's reported EPS compared to analyst estimates over recent quarters.
The chart below shows PAVmed's reported revenue compared to analyst estimates over recent quarters.
PAVmed (PAVM) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
The Actual EPS was $-1.17, which missed the estimate of $-0.71.
The Actual Revenue was $22.00K, which missed the estimate of $79.20K.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-15 | $-1.17 | $-0.71 | -64.8 % |
| Q4 | 2026-03-30 | $-1.05 | $-4.62 | 77.3 % |
| Q3 | 2025-11-13 | $-0.60 | $-6.00 | 90.0 % |
| Q2 | 2025-08-14 | $-1.50 | $-8.10 | 81.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-15 | $22.00K | $79.20K | -72.2 % |
| Q4 | 2026-03-30 | $52.00K | $25.00K | 108.0 % |
| Q3 | 2025-11-13 | $5.00K | $12.50K | -60.0 % |
| Q2 | 2025-08-14 | $6.00K | $10.00K | -40.0 % |